Kemenristek Supports Herbs to Become Immunomodulators to Recover Covid-19 Patients Without Symptoms

JAKARTA, KOMPAS.com – Chairman of the Research and Innovation Consortium Covid-19 Ministry of Research and Technology / National Research and Innovation Agency Ali Ghufron hopes for a cure herbal can be an imonumodulator to increase endurance in Covid-19 patients, especially for people without symptoms (OTG).

Ali said this via teleconference during a discussion at Graha BNPB, Jakarta, Tuesday (18/8/2020).

” Herbal Of course we hope that because of that Indonesia’s natural wealth can support immunity. And if immunity is good, now we hope especially for those with OTG or moderate, mild symptoms that can be resolved. That’s why we support it, “said Ali.

Also read: Covid-19 Patients Without Symptoms Called Sufficiently Given Vitamins and Immune Stimulus

However, Ali said there was herbal medicine which is claimed to be a drug that can cure Covid-19 patients.

In fact, he said, there are types of herbal medicines that must undergo clinical trials if they are to be called Covid-19 drug.

Herbal medicineAccording to Ali, it is divided into three types, namely herbal medicine, standardized herbal medicine (OHT), and vitopharmaca or herbal medicine whose safety has been proven through clinical trials.

“So there are three (types of herbal medicine), (types) of vitopharmaca must go through clinical trials,” he said.

“Well, this is what often apologizes for not having done a clinical trial, then he claims that this could be specifically for immunomodulators for covid,” said Ali.

Also read: BPOM: Herbal Medicines Related to Covid-19 Must Be Tested First

Previously reported, Deputy for Supervision of Traditional Medicines, Health Supplements and Cosmetics of BPOM Maya Gustina Andarini reminded that herbal medicines still have to pass various regulations to be claimed to treat a disease.

One of the most important steps to take is clinical trials.

“For an herbal medicine to be claimed, it can treat any disease. It can be circulated there must be rules,” Maya said in a press conference, Monday (10/8/2020).

“Because these patients are human. Humans must pay attention to their rights when we carry out clinical trials on them. We cannot just find, claim, let alone say that thousands of patients have already done it,” he said.

Also read: BPOM Calling Herbs in Covid-19 Treatment is Still in Testing

BPOM itself is committed to closely monitoring herbal medicinal products circulating in Indonesia, from upstream to marketing. The supervision is carried out in order to protect the community.

–